NCT05831826View on ClinicalTrials.gov

Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China

RecruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
COVID-19 VaccinesAutoimmune Diseases
Interventions
BIOLOGICAL

the inactivated COVID-19 vaccines

receive the doses of inactivated COVID-19 vaccines

Trial Locations (1)

Unknown

RECRUITING

The Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou

All Listed Sponsors
lead

Zhejiang Chinese Medical University

OTHER_GOV